Generation of transgenic human embryonic stem cell line BJNhem20-OCIAD1-OV

dc.contributor.author	Shetty, Deeti K.
dc.contributor.author	Inamdar, Maneesha S.
dc.date.accessioned	2017-01-24T06:32:23Z
dc.date.available	2017-01-24T06:32:23Z
dc.date.issued	2016
dc.identifier.citation	Shetty, D. K.; Inamdar, M. S., Generation of transgenic human embryonic stem cell line BJNhem20-OCIAD1-OV. Stem Cell Research 2016, 16 (1), 192-194 http://dx.doi.org/10.1016/j.scr.2015.12.032	en_US
dc.identifier.citation	Stem Cell Research	en_US
dc.identifier.citation	16	en_US
dc.identifier.citation	1	en_US
dc.identifier.issn	1873-5061
dc.identifier.uri	https://libjncir.jncasr.ac.in/xmlui/10572/2188
dc.description	Restricted Access	en_US
dc.description.abstract	Ovarian Carcinoma Immuno-reactive Antigen domain containing protein 1 (OCIAD1) was overexpressed in BJNhem20 human embryonic stem cell line (hESC) using plasmid transfection, followed by stable cell line generation. The construct pCAG-OCIAD1 was introduced into hESCs by microporation. (C) 2015 Published by Elsevier B.V.	en_US
dc.description.uri	1876-7753	en_US
dc.description.uri	http://dx.doi.org/10.1016/j.scr.2015.12.032	en_US
dc.language.iso	English	en_US
dc.publisher	Elsevier Science Bv	en_US
dc.rights	@Elsevier Science Bv, 2016	en_US
dc.subject	Cell Biology	en_US
dc.subject	Biotechnology & Applied Microbiology	en_US
dc.title	Generation of transgenic human embryonic stem cell line BJNhem20-OCIAD1-OV	en_US
dc.type	Article	en_US